Literature DB >> 6454745

Demonstration of a human pyrogen-inducing factor during mixed leukocyte reactions.

C A Dinarello.   

Abstract

The role of lymphocytes in the pathogenesis of fever was investigated by stimulating human blood mononuclear cells in a two-way mixed leukocyte reaction (MLR). After 2-7 d of incubation, MLR supernates contained a factor that was not pyrogenic itself when injected into rabbits; however, these supernates, when incubated with human blood monocytes from a third donor, induced the synthesis of LP. The pyrogen-inducing activity was stable at 56 degrees C, destroyed at 70 degrees C, and was neither dialyzable nor removable by adsorption by anti-human leukocytic pyrogen (LP) attached to Sepharose 4B. Production of this factor was not always correlated with increased thymidine incorporation in the MLR. Its production was absent when peripheral lymphocytes were purified over nylon wool. The concentration of mononuclear cells in the MLR varied from 5 X 10(5) to 5 X 10(6)/ml in round-bottomed tubes. Under the latter conditions, some donor cells produced this factor without stimulation in the MLR culture, but when these cells were cultured on flat-bottomed containers at low cell concentration, autologous production was not observed. These experiments demonstrate the production of a human lymphocyte factor (lymphokine) that induces LP synthesis. This pyrogen-inducing lymphokine may be important in the pathogenesis of fever in certain immunologically mediated diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454745      PMCID: PMC2186163          DOI: 10.1084/jem.153.5.1215

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Macrophage activation of allogeneic lymphocyte proliferation in the guinea pig mixed leukocyte culture.

Authors:  D K Greineder; A S Rosenthal
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

2.  Concanavalin A preparations with activities related to bacterial lipopolysaccharide.

Authors:  K W Brunson; D W Watson
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

3.  In vitro activation of a human macrophage-like cell line.

Authors:  H S Koren; S J Anderson; J W Larrick
Journal:  Nature       Date:  1979-05-24       Impact factor: 49.962

4.  Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins.

Authors:  R J Elin; S M Wolff
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Pathogenesis of fever in delayed hypersensitivity: role of monocytes.

Authors:  E Atkins; L Francis; H A Bernheim
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

7.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

8.  The production of antibody against human leukocytic pyrogen.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Studies on tuberculin fever. IV. The passive transfer of reactivity with various tissues of sensitized donor rabbits.

Authors:  W J Hall; L Francis; E Atkins
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

10.  Release of endogenous pyrogen-activating factor from concanavalin A-stimulated human lymphocytes.

Authors:  H A Bernheim; L H Block; L Francis; E Atkins
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

Authors:  Paul M Ridker
Journal:  Circ Res       Date:  2019-02       Impact factor: 17.367

2.  Failure of exogenous interleukin 1 and interleukin 2 to correct decreased lymphocyte transformation in chronic hepatitis B virus carriers.

Authors:  C Anastassakos; G J Alexander; R A Wolstencroft; D C Dumonde; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

Review 3.  Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.

Authors:  Peter Libby
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094

4.  Mechanisms of fever induced by recombinant human interferon.

Authors:  C A Dinarello; H A Bernheim; G W Duff; H V Le; T L Nagabhushan; N C Hamilton; F Coceani
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

5.  Chemical characterization of an interleukin-1-inducing substance derived from human mixed leukocyte reactions: IL-1-inducing substance is not gamma interferon.

Authors:  C A Dinarello; E F Kent
Journal:  Yale J Biol Med       Date:  1985 Mar-Apr

6.  Is fever beneficial to the host: a clinical perspective.

Authors:  G W Duff
Journal:  Yale J Biol Med       Date:  1986 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.